The Impact of COVID-19 on Pulmonary Procedures

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

COVID-19 Infection

Treatments

Other: Survey Administration

Study type

Observational

Funder types

Other

Identifiers

NCT05022446

NCI-2021-01788 (Registry Identifier)

2020-0662 (Other Identifier)

Details and patient eligibility

About

This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.

Full description

PRIMARY OBJECTIVE:

I. To assess how pulmonary medicine programs adapted their procedural practices and techniques, ambulatory operations, and provider staffing in response to the coronavirus-2019 (COVID-19) epidemic.

OUTLINE:

Participants complete survey over 5-10 minutes.

Enrollment

250 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Pulmonologists that are members of the American Association of Bronchology and Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians (ACCP)
These organizations were chosen because their member databases are composed of pulmonologists in the United States (U.S.) that perform the pulmonary procedures described in this survey. Letters of approval will be obtained from these organizations and provided to the MD Anderson Institutional Review Board (IRB). Once the MD Anderson IRB approves this survey study, the survey will be sent to the relevant subcommittees of these organizations for their electronic dissemination to their membership

Exclusion criteria

None